We have an effective vaccine for HBV in order to treat HBV patients to defeat their disease, but unfortunately, there is none against the HCV virus, despite the existence of far many more HCV patients worldwide.
Chronic HCV infection can provoke liver inflammation, bringing about degenerative organ damage, resulting in cirrhosis and hepatocellular carcinoma (liver cancer). After a first stage, chronic HCV infection appears in a rate of 75- 85 per cent of the cases. Often it leads to liver failure and subsequent liver transplantation.
Like with chronic HBV infection, in its early phase, chronic HCV infection is easily underestimated, as it does not show particular symptoms and can hardly be detected. This means that, without knowing, many persons have already been infected.